latest news releases from the newsroom
Levi & Korsinsky, LLP
Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of Hifn, Inc.
NEW YORK, Feb. 24, 2009 (GLOBE NEWSWIRE) -- Levi & Korsinsky ("L&K") is investigating breaches of fiduciary duty and other violations of state law by the board of directors of Hifn, Inc. ("Hifn" or the "Company") (Nasdaq:HIFN) arising out of their attempt to sell the Company to Exar Corporation ("Exar"). Under the terms of the proposal, Hifn's shareholders would be able to elect to receive (i) $1.60 cash and 0.3529 Exar shares for every Hifn share they own, or (ii) $4.00 in cash. The transaction is unfair given that, among other things, the Company's shares traded above $4.00 per share as recently as September 3, 2008 and analysts set a mean price target of $5.50 per share. The proposed acquisition is subject to customary conditions and regulatory approvals.
Hill International, Inc.
Hill International Schedules Release of Fourth Quarter and Full Year 2008 Financial Results and Conference Call
MARLTON, N.J., Feb. 24, 2009 (GLOBE NEWSWIRE) -- Hill International (NYSE:HIL), the global leader in managing construction risk, announced today that it will issue its financial results for the fourth quarter and full year ended December 31, 2008, on Monday, March 9, 2009, after the close of the stock market. David L. Richter, Hill's President and Chief Operating Officer, and John Fanelli III, Hill's Senior Vice President and Chief Financial Officer, will host a conference call the following morning, Tuesday, March 10, 2009, at 11:00 am Eastern Time to discuss the results.
Competitive Technologies, Inc.
Competitive Technologies' Distribution Agreements Now Cover 45% of World Population
FAIRFIELD, Conn., Feb. 24, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Alternext US:CTT) announced today that it has signed an agreement with Life Episteme srl granting them exclusive distribution rights in each of 29 countries throughout Europe, Asia, Africa, the Middle East, South America and Oceania for CTT's pain management medical device. The device is a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs.